GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137–50.

Article  PubMed Central  Google Scholar 

Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655–79.

Article  CAS  PubMed  Google Scholar 

World mental health report: transforming mental health for all; 2022. https://www.who.int/publications/i/item/9789240049338. Accessed 15 May 2023.

COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700–12.

Article  Google Scholar 

Evans-Lacko S, Aguilar-Gaxiola S, Al-Hamzawi A, et al. Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys. Psychol Med. 2018;48:1560–71.

Article  CAS  PubMed  Google Scholar 

Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–105.

Article  PubMed  Google Scholar 

Depression in adults: treatment and management. NICE guideline [NG222]. Published: 29 June 2022. https://www.nice.org.uk/guidance/ng222/chapter/Update-information. Accessed 15 May 2023.

European Society of Clinical Pharmacy (ESCP). https://escpweb.org/. Accessed 15 Aug 2023.

Stuhec M. Antipsychotic treatment in elderly patients on polypharmacy with schizophrenia. Curr Opin Psychiatry. 2022;35:332–7.

Article  PubMed  Google Scholar 

Smolders M, Laurant M, Verhaak P, et al. Adherence to evidence-based guidelines for depression and anxiety disorders is associated with recording of the diagnosis. Gen Hosp Psychiatry. 2009;31:460–9.

Article  PubMed  Google Scholar 

Stuhec M, Lah L. Clinical pharmacist interventions in elderly patients with mental disorders in primary care focused on psychotropics: a retrospective pre-post observational study. Ther Adv Psychopharmacol. 2021;11:20451253211011010.

Article  PubMed  PubMed Central  Google Scholar 

Herzog DP, Wagner S, Ruckes C, et al. Guideline adherence of antidepressant treatment in outpatients with major depressive disorder: a naturalistic study. Eur Arch Psychiatry Clin Neurosci. 2017;267:711–21.

Article  PubMed  Google Scholar 

Köhler S, Hoffmann S, Unger T, et al. Adherence to guidelines and effectiveness of inpatient treatment for unipolar depression. Int J Psychiatry Clin Pract. 2012;16:103–12.

Article  PubMed  Google Scholar 

Stuhec M, Zorjan K. Clinical pharmacist interventions in ambulatory psychogeriatric patients with excessive polypharmacy. Sci Rep. 2022;12:11387.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aguiar JP, Heitor Costa L, Alves da Costa F, et al. Identification of potentially inappropriate medications with risk of major adverse cardiac and cerebrovascular events among elderly patients in ambulatory setting and long-term care facilities. Clin Interv Aging. 2019;14:535–47.

Article  PubMed  PubMed Central  Google Scholar 

Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345–51.

Article  PubMed  Google Scholar 

Dechanont S, Maphanta S, Butthum B, et al. Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2014;23:489–97.

Article  PubMed  Google Scholar 

Aguiar JP, Brito AM, Martins AP, et al. Potentially inappropriate medications with risk of cardiovascular adverse events in the elderly: a systematic review of tools addressing inappropriate prescribing. J Clin Pharm Ther. 2019;44:349–60.

Article  PubMed  Google Scholar 

Stuhec M, Gorenc K, Zelko E. Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation. BMC Health Serv Res. 2019;19:118.

Article  PubMed  PubMed Central  Google Scholar 

Janssens B, Petrovic M, Jacquet W, et al. Medication use and its potential impact on the oral health status of nursing home residents in Flanders (Belgium). J Am Med Dir Assoc. 2017;18:809.e1-809.e8.

Article  PubMed  Google Scholar 

Mann E, Haastert B, Böhmdorfer B, et al. Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional study. Wien Klin Wochenschr. 2013;125:180–8.

Article  PubMed  Google Scholar 

Kales HC, Kim HM, Zivin K, et al. Risk of mortality among individual antipsychotics in patients with dementia. Am J Psychiatry. 2012;169:71–9.

Article  PubMed  Google Scholar 

Aguiar JP, Alves da Costa F, Egberts T, et al. The association between receptor binding affinity and metabolic side effect profile of antipsychotics and major cardio- and cerebrovascular events: a case/non-case study using VigiBase. Eur Neuropsychopharmacol. 2020;35:30–8.

Article  CAS  PubMed  Google Scholar 

Stuhec M, Locatelli I. Age-related pharmacotherapy of attention deficit hyperactivity disorder in Slovenia in children and adolescents: a population-based study. Eur Psychiatry. 2017;42:129–33.

Article  CAS  PubMed  Google Scholar 

Tiihonen J, Taipale H, Mehtälä J, et al. Association of antipsychotic polypharmacy vs monotherapy with psychiatric rehospitalization among adults with schizophrenia. JAMA Psychiat. 2019;76:499–507.

Article  Google Scholar 

Taipale H, Tanskanen A, Mehtälä J, et al. 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry. 2020;19:61–8.

Article  PubMed  PubMed Central  Google Scholar 

Taipale H, Mittendorfer-Rutz E, Alexanderson K, et al. Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. Schizophr Res. 2018;197:274–80.

Article  PubMed  Google Scholar 

Howes OD, Vergunst F, Gee S, et al. Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation. Br J Psychiatry. 2012;201:481–5.

Article  PubMed  Google Scholar 

Taylor DM, Young C, Paton C. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review. J Clin Psychiatry. 2003;64:30–4.

Article  PubMed  Google Scholar 

Correll CU, Martin A, Patel C, et al. Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics. Schizophrenia (Heidelberg). 2022;8:5.

Article  Google Scholar 

Farley JF, Hansen RA, Yu-Isenberg KS, et al. Antipsychotic adherence and its correlation to health outcomes for chronic comorbid conditions. Prim Care Companion CNS Disord. 2012;14:PCC.11m01324.

PubMed  PubMed Central  Google Scholar 

Wunderink L, Nieboer RM, Wiersma D, et al. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiat. 2013;70:913–20.

Article  Google Scholar 

Bole CB, Pišlar M, Mrhar A, et al. Prescribing patterns for inpatients with schizophrenia spectrum disorders in a psychiatric hospital in Slovenia: results of 16-month prospective, non-interventional clinical research. Psychiatr Danub. 2017;29:155–61.

Article  CAS  PubMed  Google Scholar 

Rittmannsberger H, Meise U, Schauflinger K, et al. Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics. Eur Psychiatry. 1999;14:33–40.

Article  CAS  PubMed  Google Scholar 

Aguiar JP, Gama Marques J, Leufkens HGM, et al. Healthcare professionals’ views on the management of medication complexities in the elderly with mental health disorders: a cross-sectional study. Front Psychiatry. 2022;13:885216.

Article  PubMed  PubMed Central  Google Scholar 

Aguiar JP, Bernardo C, Gama Marques J, et al. Identification of a set of patient-related features to foster safe prescribing of specific antipsychotics in the elderly with dementia. Front Psychiatry. 2020;11:604201.

Article  PubMed  PubMed Central  Google Scholar 

Virani A, Crown N. The impact of a clinical pharmacist on patient and economic outcomes in a child and adolescent mental health. Can J Hosp Pharm. 2003;56:158–62.

Google Scholar 

Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6:e010003.

Article  PubMed  PubMed Central  Google Scholar 

Javelot H, Gitahy Falcao Faria C, Vandenberghe F, et al. Clinical pharmacy in psychiatry: towards promoting clinical expertise in psychopharmacology. Pharmacy (Basel). 2021;9:146.

Article  PubMed  Google Scholar 

Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003;23:1634–44.

Article  PubMed  Google Scholar 

Richardson TE, O’Reilly CL, Chen TF. A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health. Int J Clin Pharm. 2014;36:222–32.

Article  PubMed  Google Scholar 

Gillespie C, Kleinberg F, Zogas A, et al. Perceptions of clinical pharmacy specialists’ contributions in mental health clinical teams. Ment Health Clin. 2022;12:15–22.